Skip to main navigation Skip to search Skip to main content

Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric NF2-, SMARCB1-, and LZTR1-Related Schwannomatosis

  • Melissa R. Perrino*
  • , Marjolijn C.J. Jongmans
  • , Gail E. Tomlinson
  • , Mary Louise C. Greer
  • , Sarah R. Scollon
  • , Sarah G. Mitchell
  • , Jordan R. Hansford
  • , Kris Ann P. Schultz
  • , Wendy K. Kohlmann
  • , Jennifer M. Kalish
  • , Suzanne P. MacFarland
  • , Anirban Das
  • , Kara N. Maxwell
  • , Stefan M. Pfister
  • , Rosanna Weksberg
  • , Orli Michaeli
  • , Uri Tabori
  • , Gina M. Ney
  • , Philip J. Lupo
  • , Jack J. Brzezinski
  • Douglas R. Stewart, Emma R. Woodward, Christian P. Kratz
*Corresponding author for this work
  • St. Jude Children Research Hospital
  • Princess Máxima Center for Pediatric Oncology
  • Utrecht University
  • University of Texas Health Science Center at San Antonio
  • University of Toronto
  • Baylor College of Medicine
  • Emory University
  • Adelaide University
  • Cancer and Blood Disorders
  • VA National Tele-Oncology Program
  • University of Utah
  • The Children's Hospital of Philadelphia
  • University of Pennsylvania
  • VA Medical Center
  • Heidelberg University 
  • Schneider Childrens Medical Center Israel
  • National Institutes of Health
  • Manchester University NHS Foundation Trust
  • University of Manchester
  • Hannover Medical School

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Schwannomatosis (SWN) is a distinct cancer predisposition syndrome caused by germline pathogenic variants in the genes NF2, SMARCB1, or LZTR1. There is a significant clinical overlap between these syndromes with the hallmark of increased risk for cranial, spinal, and peripheral schwannomas. Neurofibromatosis type 2 was recently renamed as NF2-related SWN and is the most common SWN syndrome, with increased risk for bilateral vestibular schwannomas, intradermal schwannomas, meningiomas, and less commonly, ependymoma. SMARCB1-related SWN is a familial SWN syndrome associated with peripheral and spinal schwannomas and an increased risk for meningiomas and malignant peripheral nerve sheath tumors, even in the absence of radiation. These individuals do not develop bilateral vestibular schwannomas. Finally, patients with LZTR1-related SWN typically present with peripheral schwannomas, and unilateral vestibular schwannomas have been reported. The following perspective is intended to highlight the clinical presentation and international tumor surveillance recommendations across these SWN syndromes.

Original languageEnglish
Pages (from-to)1400-1406
Number of pages7
JournalClinical Cancer Research
Volume31
Issue number8
DOIs
StatePublished - 15 Apr 2025
Externally publishedYes

Funding

FundersFunder number
National Institute on Handicapped Research
McClurg Foundation
Division of Cancer Epidemiology and Genetics
Hospital Research Foundation
American Lebanese Syrian Associated Charities
Manchester Biomedical Research CentreNIHR203308
Deutsche KinderkrebsstiftungDKS2024.03

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric NF2-, SMARCB1-, and LZTR1-Related Schwannomatosis'. Together they form a unique fingerprint.

    Cite this